FRI069 Treatment With Mibavademab, A Novel Leptin Receptor Agonist, Is Associated With Improvement In Weight And Associated Comorbidities In Congenital Leptin Deficiency

Disclosure: E. Ozsu: None. L. Akin: None. M. Aydin: None. M. Berberoglu: None. D. Stein: Employee; Self; Regeneron Pharmaceuticals. Stock Owner; Self; Regeneron Pharmaceuticals. O. Pagovich: Employee; Self; Regeneron Pharmaceuticals. Stock Owner; Self; Regeneron Pharmaceuticals. B. Olenchock: Employ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozsu, Elif, Akin, Leyla, Aydin, Murat, Berberoglu, Merih, Stein, David, Pagovich, Odelya, Olenchock, Ben, Podgrabinska, Simona, Harris, Charles Andrew, Mendell, Jeanne, SinhaRoy, Ranabir, Altarejos, Judith, Akinci, Baris, Oral, Elif A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Adipose Tissue, Appetite, & Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554460/
http://dx.doi.org/10.1210/jendso/bvad114.079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554460/
http://dx.doi.org/10.1210/jendso/bvad114.079

Ejemplares similares